Paul Varki insider trades

Open-market stock purchases and sales by Paul Varki, Chief Legal Officer at Avalo Therapeutics, Inc, from SEC Form 4 filings since Oct 3, 2016.

Recent trades

DateStockTradeValue
Jun 10, 2026AVTX Avalo Therapeutics, IncSold (not open market)$14.2K
May 21, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
May 6, 2026AVTX Avalo Therapeutics, IncSold$707K
May 6, 2026AVTX Avalo Therapeutics, IncSold$103K
May 6, 2026AVTX Avalo Therapeutics, IncSold$485K
May 6, 2026AVTX Avalo Therapeutics, IncSold$210K
May 6, 2026AVTX Avalo Therapeutics, IncSold$9.5K
May 6, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
May 6, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
Feb 26, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
Dec 10, 2025AVTX Avalo Therapeutics, IncSold (not open market)$4.2K

Companies traded

  • AVTX Avalo Therapeutics, Inc: 5 sales, last Jun 10, 2026
  • EGLT Egalet Corp: 4 sales, last Jul 3, 2017

Get free alerts when Paul Varki files a new trade →